Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |